Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.

Veterinary and comparative oncology - 1 Jun 2024

Kambayashi Satoshi, Ono Nanae, Tone Tomofumi, Baba Kenji, Okuda Masaru

Abstract excerpt

Canine lymphoma is a disease with high morbidity and poor long-term prognosis, despite a high response rate to chemotherapy. In this study, we focused on liquid biopsy, in which small amounts of substances from body fluids were analysed, to determine whether cell-free DNA (cfDNA) in the plasma can be used as a biomarker for lymphoma in dogs. We found that 23 patients with lymphoma had significantly higher cfDNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Dog Diseases

Share to Genotype

Share to Lymphoma

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 38287199
DOI: 10.1111/vco.12961

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.PMID 38287199Read ↗

Interest of circulating tumor DNA as a biomarker for canine cancers: illustration in histiocytic sarcoma, oral malignant melanoma and multicentric lymphomaSemantic proximity Read ↗

Analysis of cell-free DNA concentration, fragmentation patterns and TP53 gene expression in mammary tumor-bearing dogs: A pilot studySemantic proximity Read ↗

Cell-free DNA and the monitoring of lymphoma treatment.Semantic proximity Read ↗

Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma.Semantic proximity Read ↗

The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomasSemantic proximity Read ↗

Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in DogsSemantic proximity Read ↗

Quantitative analysis of the BRAF V595E mutation in plasma cell-free DNA from dogs with urothelial carcinoma.Semantic proximity Read ↗

Development of the polymerase chain reaction assay based on the canine genome database for detection of monoclonality in B cell lymphomaSemantic proximity Read ↗

Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.Semantic proximity Read ↗

Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumorsSemantic proximity Read ↗

Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.Semantic proximity Read ↗

Quantification of cell-free DNA for the analysis of CD19-CAR-T cells during lymphoma treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.